Imagin Medical Inc.

OTCPK:IMEX.F Stock Report

Market Cap: US$112.3k

Imagin Medical Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Jim Hutchens

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure8.9yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure6yrs

Recent management updates

No updates

Recent updates

CEO Compensation Analysis

How has Jim Hutchens's remuneration changed compared to Imagin Medical's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2023n/an/a

-CA$3m

Mar 31 2023n/an/a

-CA$879k

Dec 31 2022n/an/a

-CA$1m

Sep 30 2022CA$448kCA$448k

-CA$2m

Jun 30 2022n/an/a

-CA$6m

Mar 31 2022n/an/a

-CA$11m

Dec 31 2021n/an/a

-CA$12m

Sep 30 2021CA$570kCA$558k

-CA$11m

Jun 30 2021n/an/a

-CA$4m

Mar 31 2021n/an/a

-CA$4m

Dec 31 2020n/an/a

-CA$4m

Sep 30 2020CA$603kCA$603k

-CA$4m

Jun 30 2020n/an/a

-CA$5m

Mar 31 2020n/an/a

-CA$6m

Dec 31 2019n/an/a

-CA$5m

Sep 30 2019CA$649kCA$649k

-CA$4m

Jun 30 2019n/an/a

-CA$5m

Mar 31 2019n/an/a

-CA$6m

Dec 31 2018n/an/a

-CA$8m

Sep 30 2018CA$2mCA$469k

-CA$8m

Compensation vs Market: Insufficient data to establish whether Jim's total compensation is reasonable compared to companies of similar size in the US market.

Compensation vs Earnings: Insufficient data to compare Jim's compensation with company performance.

CEO

Jim Hutchens

8.9yrs

Tenure

CA$448,311

Compensation

Mr. Edward James Hutchens, also known as Jim, is the Co-founder and Managing Director of Origin Partners. Mr. Hutchens has been Chief Executive Officer and President of Imagin Medical Inc. since February 2...

Board Members

NamePositionTenureCompensationOwnership
Edward Hutchens
CEO, President & Director8.9yrsCA$448.31kno data
Christopher Bleck
Independent Director6.3yrsCA$6.00kno data
Mark Emberton
Medical Advisor of Prostate Cancerno datano datano data
Ashish Kamat
Medical Advisor of Bladder Cancer5.8yrsno datano data
Kenneth Daignault
Independent Director8.3yrsCA$6.00kno data
Trinity Bivalacqua
Medical Advisor of Bladder Cancerno datano datano data
Kevin Slawin
Independent Chairman of the Board3.3yrsCA$6.00kno data
Samir Taneja
Medical Advisor of Prostate Cancerno datano datano data
Kayvon Namvar
Independent Director3.2yrsCA$5.50kno data
Clement Orczyk
Medical Advisor of Prostate Cancerno datano datano data
Richard Matulewicz
Medical Advisor of Bladder Cancerno datano datano data
Fernando Bianco
Medical Advisor of Prostate Cancerno datano datano data

6.0yrs

Average Tenure

Experienced Board: IMEX.F's board of directors are considered experienced (6 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/19 19:43
End of Day Share Price 2025/01/02 00:00
Earnings2023/06/30
Annual Earnings2022/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Imagin Medical Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution